Cosenza-Nashat Melissa, Zhao Meng-Liang, Marshall Heather D, Si Qiusheng, Morgello Susan, Lee Sunhee C
Department of Pathology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
J Neurovirol. 2007 Dec;13(6):536-48. doi: 10.1080/13550280701549417.
It is well known that infection by the human immunodeficiency virus (HIV) dysregulates cell physiology, but little information is available on the consequences of HIV infection in primary macrophages and microglia. The authors examined the relationship between cell proliferation and HIV infection in primary cultures of microglia and in human central nervous system (CNS). In cultures infected with HIV (ADA and BaL), granulocyte-macrophage colony-stimulating factor (GM-CSF)-mediated cell proliferation was reduced in productively infected (p24+) cells as compared to p24- cells. The reduction was observed with both Ki67 and BrdU labeling, suggesting a G1/S block. The reduction was insignificant when microglia were infected with a Vpr- mutant virus. In human CNS, proliferating (Ki67+) cells were rare but were increased in the HIV+ and HIV encephalitis (HIVE) groups compared to the HIV- group. A positive correlation between GM-CSF immunoreactivity and Ki67 counts, implicating GM-CSF as a growth factor in human CNS was found. The relationship between total macrophage (CD68+) proliferation and infected macrophage (p24+) proliferation was assessed in HIVE by double labeling. Whereas 1.2% of total CD68+ cells were Ki67+, only 0.5% of HIV p24+ cells were Ki67+ (P < .05). Furthermore, staining for CD45RB (as opposed to CD68) facilitated the identification of Ki67+ microglia, indicating that CD68 could underestimate proliferating microglia. The authors conclude that although there is increased expression of GM-CSF and increased cell proliferation in the CNS of HIV-seropositive individuals, cell proliferation in the productively infected population is actually suppressed. These data suggest that there might be a viral gain in the suppressed host cell proliferation.
众所周知,人类免疫缺陷病毒(HIV)感染会破坏细胞生理功能,但关于HIV感染对原代巨噬细胞和小胶质细胞的影响却知之甚少。作者研究了小胶质细胞原代培养物以及人类中枢神经系统(CNS)中细胞增殖与HIV感染之间的关系。在感染HIV(ADA和BaL)的培养物中,与p24阴性细胞相比,在高效感染(p24阳性)的细胞中,粒细胞-巨噬细胞集落刺激因子(GM-CSF)介导的细胞增殖减少。用Ki67和BrdU标记均观察到这种减少,提示存在G1/S期阻滞。当小胶质细胞感染Vpr突变病毒时,这种减少不明显。在人类CNS中,增殖(Ki67阳性)细胞很少见,但与HIV阴性组相比,HIV阳性和HIV脑炎(HIVE)组中的增殖细胞增加。发现GM-CSF免疫反应性与Ki67计数之间呈正相关,这表明GM-CSF在人类CNS中是一种生长因子。通过双重标记评估了HIVE中总巨噬细胞(CD68阳性)增殖与感染巨噬细胞(p24阳性)增殖之间的关系。虽然总CD68阳性细胞中有1.2%为Ki67阳性,但HIV p24阳性细胞中只有0.5%为Ki67阳性(P<0.05)。此外,CD45RB染色(与CD68相反)有助于识别Ki67阳性小胶质细胞,表明CD68可能会低估增殖的小胶质细胞。作者得出结论,尽管HIV血清阳性个体的CNS中GM-CSF表达增加且细胞增殖增加,但高效感染群体中的细胞增殖实际上受到抑制。这些数据表明,在被抑制的宿主细胞增殖中可能存在病毒获益。